Optimizing Pre-Clinical Drug Development through Immune Receptor Sequencing in Mouse Models: Upcoming Webinar Hosted by Xtalks

In this free webinar, learn about optimizing pre-clinical drug development by decoding genetic information stored in the adaptive immune system’s T-cell and B-cell receptors.

TORONTO, Ontario and SEATTLE, Oct. 28, 2022 /PRNewswire-PRWeb/ — Attendees will learn about the basics of immune receptor profiling, as well as how immunosequencing can be applied to advance drug discovery and develop targeted therapies. The featured speaker will discuss how to use immunosequencing in pre-clinical mouse models to identify biomarkers and prioritize drug candidates.

Join Patrick Raber, Ph.D., Director, Immune Medicine at Adaptive Biotechnologies, for the live webinar on Thursday, November 10, 2022 at 1 p.m. Eastern/10 a.m. Pacific.

For more information, or to register for this event, visit Optimizing Pre-Clinical Drug Development through Immune Receptor Sequencing in Mouse Models.

For Research Use Only. Not for use in diagnostic procedures.

ABOUT ADAPTIVE BIOTECHNOLOGIES

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development and develop clinical diagnostics across our two business areas: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable diagnosis, monitoring and treatment for diseases such as cancer, autoimmune disorders and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

To learn more about Adaptive Biotechnologies, visit http://adaptivebiotech.com/

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (life science, food and medical device companies, private and academic research institutions, and healthcare centers, among others) turn to Xtalks for access to quality content. Xtalks helps life science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

 

SOURCE Xtalks

Optimizing Pre-Clinical Drug Development through Immune Receptor Sequencing in Mouse Models: Upcoming Webinar Hosted by Xtalks WeeklyReviewer

PR Newswire Science News

World Reviewer Staff
World Reviewer Staffhttps://weeklyreviewer.com/
The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Latest articles

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

Related articles

WeeklyReviewer